U.S. flag

An official website of the United States government

NM_000536.4(RAG2):c.104G>T (p.Gly35Val) AND Histiocytic medullary reticulosis

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 2, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001834860.1

Allele description [Variation Report for NM_000536.4(RAG2):c.104G>T (p.Gly35Val)]

NM_000536.4(RAG2):c.104G>T (p.Gly35Val)

Gene:
RAG2:recombination activating 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p12
Genomic location:
Preferred name:
NM_000536.4(RAG2):c.104G>T (p.Gly35Val)
HGVS:
  • NC_000011.10:g.36594065C>A
  • NG_007573.1:g.9172G>T
  • NG_033154.1:g.4573C>A
  • NM_000536.4:c.104G>TMANE SELECT
  • NM_001243785.2:c.104G>T
  • NM_001243786.2:c.104G>T
  • NP_000527.2:p.Gly35Val
  • NP_001230714.1:p.Gly35Val
  • NP_001230715.1:p.Gly35Val
  • LRG_99:g.9172G>T
  • NC_000011.9:g.36615615C>A
  • NM_000536.3:c.104G>T
Protein change:
G35V
Links:
dbSNP: rs148508754
NCBI 1000 Genomes Browser:
rs148508754
Molecular consequence:
  • NM_000536.4:c.104G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243785.2:c.104G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243786.2:c.104G>T - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
effect on catalytic protein function [Variation Ontology: 0008]

Condition(s)

Name:
Histiocytic medullary reticulosis
Synonyms:
Omenn syndrome; Reticuloendotheliosis familial with eosinophilia; Severe combined immunodeficiency with hypereosinophilia
Identifiers:
MONDO: MONDO:0011338; MedGen: C2700553; Orphanet: 39041; OMIM: 603554

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002087229Natera, Inc.
no assertion criteria provided
Pathogenic
(Jun 2, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002087229.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024